These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 25376109)

  • 1. Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?
    Kob R; Bollheimer LC; Bertsch T; Fellner C; Djukic M; Sieber CC; Fischer BE
    Biogerontology; 2015 Feb; 16(1):15-29. PubMed ID: 25376109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis.
    Kalinkovich A; Livshits G
    Ageing Res Rev; 2017 May; 35():200-221. PubMed ID: 27702700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age--An overview.
    Buch A; Carmeli E; Boker LK; Marcus Y; Shefer G; Kis O; Berner Y; Stern N
    Exp Gerontol; 2016 Apr; 76():25-32. PubMed ID: 26785313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Syndrome and Sarcopenia.
    Nishikawa H; Asai A; Fukunishi S; Nishiguchi S; Higuchi K
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review.
    Li CW; Yu K; Shyh-Chang N; Jiang Z; Liu T; Ma S; Luo L; Guang L; Liang K; Ma W; Miao H; Cao W; Liu R; Jiang LJ; Yu SL; Li C; Liu HJ; Xu LY; Liu RJ; Zhang XY; Liu GS
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):781-794. PubMed ID: 35106971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
    Biolo G; Cederholm T; Muscaritoli M
    Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia and sarcopenic obesity.
    Choi KM
    Korean J Intern Med; 2016 Nov; 31(6):1054-1060. PubMed ID: 27809450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished anabolic signaling response to insulin induced by intramuscular lipid accumulation is associated with inflammation in aging but not obesity.
    Rivas DA; McDonald DJ; Rice NP; Haran PH; Dolnikowski GG; Fielding RA
    Am J Physiol Regul Integr Comp Physiol; 2016 Apr; 310(7):R561-9. PubMed ID: 26764052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Vicious Cycle of Myostatin Signaling in Sarcopenic Obesity: Myostatin Role in Skeletal Muscle Growth, Insulin Signaling and Implications for Clinical Trials.
    Consitt LA; Clark BC
    J Frailty Aging; 2018; 7(1):21-27. PubMed ID: 29412438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Nutritional Supplements on Gut-Muscle Axis Across Age: a Mini-Review.
    Nucci RAB; Filho VAN; Jacob-Filho W; Otoch JP; Pessoa AFM
    Cell Physiol Biochem; 2023 May; 57(3):161-168. PubMed ID: 37190847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenia.
    Morley JE; Baumgartner RN; Roubenoff R; Mayer J; Nair KS
    J Lab Clin Med; 2001 Apr; 137(4):231-43. PubMed ID: 11283518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenic obesity: satellite cells in the aging muscle.
    Thornell LE
    Curr Opin Clin Nutr Metab Care; 2011 Jan; 14(1):22-7. PubMed ID: 21088571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The decline in muscle strength and muscle quality in relation to metabolic derangements in adult women with obesity.
    Poggiogalle E; Lubrano C; Gnessi L; Mariani S; Di Martino M; Catalano C; Lenzi A; Donini LM
    Clin Nutr; 2019 Oct; 38(5):2430-2435. PubMed ID: 30792144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2 deficiency exacerbates frailty and sarcopenia by impairing skeletal muscle mitochondrial biogenesis and dynamics in an age-dependent manner.
    Huang DD; Fan SD; Chen XY; Yan XL; Zhang XZ; Ma BW; Yu DY; Xiao WY; Zhuang CL; Yu Z
    Exp Gerontol; 2019 May; 119():61-73. PubMed ID: 30690066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of obesity on skeletal muscle strength and structure through adolescence to old age.
    Tomlinson DJ; Erskine RM; Morse CI; Winwood K; Onambélé-Pearson G
    Biogerontology; 2016 Jun; 17(3):467-83. PubMed ID: 26667010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Consequences of Sarcopenic Obesity: A Narrative Review.
    Roh E; Choi KM
    Front Endocrinol (Lausanne); 2020; 11():332. PubMed ID: 32508753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenic obesity: Time to meet the challenge.
    Barazzoni R; Bischoff SC; Boirie Y; Busetto L; Cederholm T; Dicker D; Toplak H; Van Gossum A; Yumuk V; Vettor R
    Clin Nutr; 2018 Dec; 37(6 Pt A):1787-1793. PubMed ID: 29857921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifactorial Mechanism of Sarcopenia and Sarcopenic Obesity. Role of Physical Exercise, Microbiota and Myokines.
    Bilski J; Pierzchalski P; Szczepanik M; Bonior J; Zoladz JA
    Cells; 2022 Jan; 11(1):. PubMed ID: 35011721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenic Obesity: Time to Meet the Challenge.
    Barazzoni R; Bischoff S; Boirie Y; Busetto L; Cederholm T; Dicker D; Toplak H; Van Gossum A; Yumuk V; Vettor R
    Obes Facts; 2018; 11(4):294-305. PubMed ID: 30016792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia: characteristics, mechanisms and functional significance.
    Narici MV; Maffulli N
    Br Med Bull; 2010; 95():139-59. PubMed ID: 20200012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.